To further benchmark the diagnostic performance of miRNAs against the established biomarker NT-proBNP, we focused on a subset of DCM patients with NT-proBNP values below the median observed in HF cases (790 pg/mL; n = 294). The gene discussed is NPPB; the disease is familial dilated cardiomyopathy.